Articles with "center randomized" as a keyword



Paclitaxel plus nedaplatin vs. paclitaxel plus carboplatin in women with epithelial ovarian cancer: A multi-center, randomized, open-label, phase III trial.

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2018.36.15_suppl.e17519

Abstract: e17519Background: The multi-center, randomized, open-lable, phaseⅢ trial discussed in the present study was performed to compare clinical outcomes of nedaplatin (NDP) plus paclitaxel, and carboplat... read more here.

Keywords: randomized open; multi center; center randomized; paclitaxel plus ... See more keywords

A Comparative Evaluation of the Safety and Efficacy of Oliceridine and Sufentanil in Gastrointestinal Endoscopy: A Single-Center, Randomized Controlled Trial

Sign Up to like & get
recommendations!
Published in 2025 at "Drug Design, Development and Therapy"

DOI: 10.2147/dddt.s512529

Abstract: Purpose Gastrointestinal (GI) endoscopic sedation employs a range of medication regimens; however, safer and more effective sedation protocols must be identified. Oliceridine, a novel biased µ-opioid receptor agonist, can reduce opioid-related adverse events. However, compared… read more here.

Keywords: center randomized; oliceridine sufentanil; single center; trial ... See more keywords

Efficacy and Safety of Bushen Jiedu Tongluo Decoction in Active Rheumatoid Arthritis: Study Protocol for a Multi-Center, Randomized, Double-Blind, Controlled Trial

Sign Up to like & get
recommendations!
Published in 2025 at "Journal of Pain Research"

DOI: 10.2147/jpr.s512681

Abstract: Introduction Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease with the primary clinical symptoms of joint swelling and pain. Among the currently available therapeutic agents, methotrexate (MTX) is an internationally recognized first-line disease-modifying antirheumatic… read more here.

Keywords: double blind; center randomized; trial; randomized double ... See more keywords